Kenvue LLC, as successor in interest to Kenvue Inc., filed a Post-Effective Amendment No. 1 to Registration Statement No. 333-274376 on November 2, 2026, to remove from registration all debt securities registered but unsold under that statement following the completion of Kimberly-Clark Corporation's acquisition …
CBIZ, Inc. Chief Accounting Officer Michael T. Mangan filed a Form 4 on November 2, 2026, reporting the cancellation and conversion of 7,633.4082 shares of CBIZ common stock following the completion of a merger with Viking MergerCo, Inc.
VivoPower PLC filed its annual report on Form 20-F with the SEC on November 2, 2026, covering the fiscal year ended June 30, 2026, and disclosing, among other items, the completion of the Mo i Rana Acquisition in Norway.
Lead Real Estate Co., Ltd (NASDAQ:LRE) filed its annual report on Form 20-F with the U.S. Securities and Exchange Commission on November 2, 2026, covering the fiscal year ended June 30, 2026.
Marita Zuraitis, an officer and director of Horace Mann Educators Corp, filed a Form 144 notice on November 2, 2026, proposing the sale of 7,500 shares of common stock with an aggregate market value of $353,973.01 through Fidelity Brokerage Services LLC on NYSE.
Murphy USA Inc. officer Donald R. Smith Jr. filed a Form 144 notice of proposed sale of 1,460 shares of Murphy USA common stock on November 2, 2026, through Fidelity Brokerage Services LLC on the NYSE.
Liberty Energy Inc. Chief Financial Officer Michael Stock filed a Form 4 on November 2, 2026, disclosing the sale of 3,333 shares of Class A Common Stock at $16.74 per share under a pre-established Rule 10b5-1 trading plan.
Kiniksa Pharmaceuticals International, plc officer Mark Ragosa filed a Form 144 notice of proposed sale of 36,783 Class A ordinary shares on November 2, 2026, with the transaction stemming from a cashless employee stock option exercise.
Jeffrey S. Lorberbaum, an affiliate of Mohawk Industries Inc, filed a Form 144 notice of proposed sale with the SEC on November 2, 2026, covering 10,000 shares of Mohawk Industries common stock with an aggregate market value of $1,483,444.00.
Christine Poon, a director of Regeneron Pharmaceuticals, Inc., filed a Form 144 notice of proposed sale on November 2, 2026, covering 7,830 shares of Regeneron common stock with an aggregate market value of $7,526,665.80.